Dana-Farber Tells Fed. Circ. Not To Revisit Inventorship Ruling

By Tiffany Hu · September 15, 2020, 6:08 PM EDT

The Dana-Farber Cancer Institute is urging the full Federal Circuit not to reconsider a panel decision requiring a pair of American scientists to be named as co-inventors on patents involved in...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Dana-Farber Cancer Institute v. Ono Pharmaceutical Co., Ltd.

Case Number

19-2050

Court

Appellate - Federal Circuit

Nature of Suit

830 Patent Infringement (Fed. Question)

Date Filed

June 19, 2019